Usefulness of Pharmacogenomics in Clinical Practice
Project/Area Number |
17K15504
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Medical pharmacy
|
Research Institution | Ritsumeikan University |
Principal Investigator |
Hira Daiki 立命館大学, 薬学部, 助教 (50636959)
|
Project Period (FY) |
2017-04-01 – 2020-03-31
|
Project Status |
Completed (Fiscal Year 2019)
|
Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2018: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Keywords | 個別医療 / 遺伝子多型解析 / 医療薬学 / 遺伝子検査 / 疼痛管理 |
Outline of Final Research Achievements |
In this study, the impact of the CYP2D6 polymorphism on the effect of Tramadol was evaluated to explain the individual difference in analgesic. There are few genetic variants in which the activity of CYP2D6 is extremely decreased in Japanese people. However, even genetic polymorphisms in which the activity of CYP2D6 is slightly decreased, which, which are frequently observed in Japanese, significantly affect the efficacy of Tramadol.
|
Academic Significance and Societal Importance of the Research Achievements |
本研究では、薬物の効果の個人差を遺伝子変異の有無により説明することを目的としている。遺伝子変異の評価に基づいて個々の患者さんに合わせた薬剤選択や投与量決定が可能となれば、(1) いち早く最適な治療効果が達成できることによる治療効率の向上や、(2) 過剰投与が防止できることによる副作用頻度の低下という医学的なメリットに加え、(3) 投与量の最適化による薬剤費の負担軽減や、(4) 副作用頻度の低減による副作用の治療のための医療費の軽減など、経済学的なメリットが期待できる。
|
Report
(4 results)
Research Products
(27 results)
-
-
-
-
-
[Journal Article] Exploratory Investigation of Target Pazopanib Concentration Range for Patients With Renal Cell Carcinoma2019
Author(s)
Satoshi Noda, Tetsuya Yoshida, Daiki Hira, Ryosuke Murai, Keiji Tomita, Teruhiko Tsuru, Susumu Kageyama, Akihiro Kawauchi, Yoshito Ikeda, Shin-ya Morita, Tomohiro Terada.
-
Journal Title
Clinical Genitourinary Cancer
Volume: 17
Issue: 2
Pages: e306-e313
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
[Journal Article] Population pharmacokinetics and pharmacogenomics of apixaban in Japanese adult patients with atrial fibrillation.2018
Author(s)
Ueshima S, Hira D, Kimura Y, Fujii R, Tomitsuka C, Yamane T, Tabuchi Y, Ozawa T, Itoh H, Ohno S, Horie M, Terada T, Katsura T.
-
Journal Title
Br. J. Clin. Pharmacol.
Volume: -
Issue: 6
Pages: 1301-1312
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Impact of ABCB1, ABCG2, and CYP3A5 polymorphisms on plasma trough concentrations of apixaban in Japanese patients with atrial fibrillation2017
Author(s)
Satoshi Ueshima, Daiki Hira, Ryo Fujii, Yuuma Kimura, Chiho Tomitsuka, Takuya Yamane, Yohei Tabuchi, Tomoya Ozawa, Hideki Itoh, Minoru Horie, Tomohiro Terada, Toshiya Katsura
-
Journal Title
Pharmacogenetics and Genomics
Volume: 27
Issue: 9
Pages: 329-336
DOI
Related Report
Peer Reviewed
-
-
-
-
-
[Presentation] 薬物代謝酵素の遺伝子多型測定に基づくトラマドールの個別化投与設計2018
Author(s)
平 大樹, 岩下成人, 神谷貴樹, 中島 亮, 磯野哲一郎, 赤羽理也, 池田義人, 角本幹夫, 森田真也, 岡野友信, 今井晋二, 福井 聖, 寺田智祐
Organizer
第40回 日本疼痛学会
Related Report
-
-
-
-
-